Engineers and oncologists teamed up to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes.

Engineers and oncologists teamed up to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes.
Demoted from her tenure track position in the mid 90s, Katalin Karikó persisted with her research into RNA therapeutics and is now senior vice president of BioNtech.
Nvel tuberculosis vaccine demonstrated strong immune response in mice.
The first digital CRISPR/Cas‐assisted assay that can detect SARS‐CoV‐2 in under 30 minutes.
Small changes in societies’ behaviors could lead to positive cascading effects that will mitigate climate change.
The Argentinean experience can inform experts on LEEN efforts to make industrial sectors more energy efficient in developing regions.
Creating antiviral drugs to help treat infected patients is more important than ever. Now, researchers report a non-toxic macrocycle antiviral agent that shows high efficacy against several influenza strains.
The global COVID-19 pandemic has changed the way in which we teach, but it doesn’t have to be all bad.
The companies announce the first emergency approval of their mRNA vaccine against COVID-19, with rollout to begin next week.
Scientists uncover how a sensor protein activates our immune system against the common cold. The findings may lead to more effective treatments of flu-like symptoms.